
    
      The aim of this trial is to study immunosuppression biomarkers in patients hospitalized in
      intensive care unit in comparison to non-septic patients.

      Prevalence of immunosuppression acquired in intensive care unit will be studied and patients
      most likely to develop nosocomial infection will be early identified
    
  